Emerging Cellular Therapies (Q5)
January 22-25, 2024
| Santa Fe Community Convention Center, Santa Fe, NM, United States
Dan S. Kaufman, Kiem and Sonja Schrepfer
Scholarship Deadline: Oct. 30, 2023 | Abstract Deadline: Oct. 30, 2023 | Early Registration Deadline: Nov. 21, 2023
| 4:00–8:00 PM |
Arrival and Registration |
Sweeney Ballroom Foyer |
| 6:00–8:00 PM |
Welcome Mixer |
Sweeney Ballroom Foyer |
Tuesday, January 23, 2024
| 7:00–8:00 AM |
Breakfast |
Sweeney Ballroom F |
| 7:30–8:00 AM |
Poster Setup |
Sweeney Ballroom F |
| 8:00–9:30 AM |
Welcome and Keynote Session (Joint) |
Sweeney Ballroom A-B |
| |
Drew Weissman, University of Pennsylvania
In vivo LNP-mRNA Therapies |
|
| |
Juan Carlos Izpisua-Belmonte, Altos Labs
in vivo Reprogramming for Rejuvenation |
|
| 8:00–7:00 PM |
Poster Viewing |
Sweeney Ballroom F |
| 9:30–9:50 AM |
Coffee Break |
Sweeney Ballroom Foyer |
| 9:50–11:15 AM |
Cell Engineering and Regenerative Therapies (Joint) |
Sweeney Ballroom A-B |
| |
Yvonne Y. Chen, University of California, Los Angeles
Programming Novel Cancer Therapeutics |
|
| |
Masayo Takahashi, RIKEN Center for Developmental Biology
Cell and Gene Therapy for Retinal Regeneration |
|
| |
Vardhman Kumar, MIT
Short Talk: Short Talk: Injectable and Modular Multicellular Liver Tissue Engineering |
|
| |
Irene Lorenzo Llorente, Stanford University
Short Talk: Short Talk: Allogeneic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia |
|
| 11:30–12:30 PM |
Lunch |
Sweeney Ballroom F |
| 12:00–2:30 PM |
Poster Session 1 |
Sweeney Ballroom F |
| 3:00–4:30 PM |
Career Roundtable (Joint) |
|
| |
Samik Basu, Cabaletta Bio
Chief Scientific Officer |
|
| |
Maria Pia E. Cosma, Centre for Genomic Regulation
ICREA Research Professor and Senior Scientist |
|
| |
Katy Rezvani, University of Texas MD Anderson Cancer Center
Professor |
|
| |
Quinton Smith, University of California, Irvine
Assistant Professor |
|
| 4:30–5:00 PM |
Coffee Available |
Sweeney Ballroom Foyer |
| 5:00–7:00 PM |
Strategies for Engineered Cell Therapies |
Sweeney Ballroom A-B |
| |
Jonathan Yen, St. Jude Children's Research Hospital
Therapeutic Genome Editing of Hematopoietic Stem Cells for the Treatment of Sickle Cell Disease |
|
| |
Paula M. Cannon, University of Southern California, Keck School of Medicine
Genome Edited B Cells for Custom Antibody Production |
|
| |
Hans-Peter Kiem, Fred Hutchinson Cancer Center
New Approaches for Cell Therapy Against Malignant and Infectious Disease |
|
| |
Robert Mabry, Orna Therapeutics
Short Talk: Short Talk: ORN-101 isCAR Therapy for the Treatment of B Cell Malignancies |
|
| |
Hanlan Liu, Be Bio
Short Talk: Short Talk: Development of an Ex Vivo Precision Gene Engineered B Cell Medicine Platform that Produces Active and Sustained Levels of Therapeutic Proteins with Broad Utility in Rare Diseases and Cancer |
|
| 7:00–8:00 PM |
On Own for Dinner |
|
Wednesday, January 24, 2024
| 7:00–8:00 AM |
Breakfast |
Sweeney Ballroom F |
| 8:00–11:00 AM |
iPSC-Derived Therapies for Non-Malignant Disease |
Sweeney Ballroom A-B |
| |
Sonja Schrepfer, University of California, San Francisco and Sana Biotechnology
Production of Immune Privileged iPSCs |
|
| |
Lorenz Studer, Memorial Sloan Kettering Cancer Center
iPSC-Derived Treatment for Parkinson's Disease |
|
| |
Steven Havlicek, Neurona Therapeutics
NRTX-1001 - A Human Pluripotent Stem Cell-Derived Inhibitory Interneuron Cell Therapy For Drug-Refractory Focal Epilepsy: From Preclinical Characterization To First Clinical Trial Results |
|
| |
Christine L. Mummery, Leiden University Medical Center
Discovering Therapies for the CVD using hiPSC |
|
| |
Hans-Willem E. Snoeck, Columbia University Medical Center
Short Talk: Short Talk: Engraftment and Injury Repair in Regionally Conditioned Rat Lung in vivo by Lung Progenitors Derived from Human Pluripotent Stem Cells |
|
| |
Sophia Silver, Clemson University
Short Talk: Short Talk: Nanowired Human Cardiac Organoid Transplantation Enables Highly Efficient and Effective Recovery of Infarcted Hearts |
|
| 9:00–9:20 AM |
Coffee Break |
Sweeney Ballroom Foyer |
| 11:00–1:00 PM |
Poster Setup |
Sweeney Ballroom F |
| 11:00–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
Sweeney Ballroom F |
| 2:30–4:30 PM |
Workshop: Advances in Cell Therapies |
Sweeney Ballroom A-B |
| |
Tina Tylek, Drexel University
Biomaterial-enabled Macrophage Cell Therapy for Regenerative Medicine |
|
| |
Sandra Petrus-Reurer, University of Cambridge
Generation and Characterization of ‘Universal’ Low-Immunogenic Human Primary Cholangiocyte Organoids for Treatment of Bile Duct Disorders |
|
| |
Nicholas Kalogriopoulos, Stanford University
Programmable Synthetic GPCRs for Customized Antigen-dependent Control of Cell Behaviors |
|
| |
May Daher, MD Anderson Cancer Center
Myeloid Blasts Induce an Irreversible Epigenetic Scar in NK Cells Leading to a Global Dysfunction |
|
| |
Christopher Chang, UCSF
One-step Enrichment of Cells with Multi-locus Knockins through SEED-Selection |
|
| |
Crystal Chen, Stanford University
Autonomous T Cell Activation-inducible mRNA Switches for Enhanced Cell Therapy |
|
| |
Yuxiao Wang, Myeloid Therapeutics
Novel Chimeric Antigen Receptors for In Vivo Programing of Immune Cells to Target Cancer |
|
| 4:30–5:00 PM |
Coffee Available |
Sweeney Ballroom Foyer |
| 5:00–7:00 PM |
Novel Cancer Cell Therapies |
Sweeney Ballroom A-B |
| |
Dan S. Kaufman, University of California, San Diego
Engineered iPSC-Derived Immune Cells for Improved Cancer Therapies |
|
| |
Katy Rezvani, University of Texas MD Anderson Cancer Center
Clinical Translation of Engineered NK Cell-Based Therapies |
|
| |
Avery D. Posey, University of Pennsylvania
Novel Targets for CAR-T Cell-Based Therapy |
|
| |
Amy N. Courtney, Baylor College of Medicine
Short Talk: Short Talk: Allogeneic NKT Cells Expressing a CD19-specific CAR in Patients with Relapsed or Refractory B Cell Malignancies: An Interim Analysis |
|
| |
Theodoros Giavridis, Mnemo Therapeutics, Inc.
Short Talk: Short Talk: Identification of Novel, Recurrent Tumor-specific Targets for Next-generation Cancer Immunotherapies |
|
| 7:00–8:00 PM |
Social Hour with Lite Bites |
Sweeney Ballroom F |
| 7:30–10:00 PM |
Poster Session 2 |
Sweeney Ballroom F |
Thursday, January 25, 2024
| 7:00–8:00 AM |
Breakfast |
Sweeney Ballroom F |
| 8:00–11:00 AM |
Cell Therapy for Infectious Disease and Autoimmune Disease |
Sweeney Ballroom A-B |
| |
Silke Paust, The Jackson Laboratory for Genomic Medicine
Remote Presentation: Mechanisms that Regulate NK Cell Anti-Viral Activity |
|
| |
Corina Amor, Cold Spring Harbor Laboratory
Short Talk: Short Talk: Prophylactic and Long-lasting Efficacy of Senolytic CAR T Cells Against Age-related Phenotypes |
|
| |
Samik Basu, Cabaletta Bio
CD19 CAR-T Cells for the Treatment of Autoimmune Disease |
|
| |
Helen Heslop, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's
Anti-Viral Cell Therapy |
|
| |
Mila Bjelica, CHU Sainte Justine
Short Talk: Short Talk: Developing CAR-NK Cells Against Severe Acute Respiratory Syndrome Coronavirus 2 for Immunocompromised Individuals |
|
| 9:00–9:20 AM |
Coffee Break |
Sweeney Ballroom Foyer |
| 11:00–5:00 PM |
On Own for Lunch |
|
| 4:30–5:00 PM |
Coffee Available |
Sweeney Ballroom Foyer |
| 5:00–6:45 PM |
HSC and Gene Therapy (Joint) |
Sweeney Ballroom A-B |
| |
Emmanuelle Passegué, Columbia University
Metabolic and Stress Regulation of HSCs |
|
| |
Raffaella Di Micco, Ospedale San Raffaele
Mechanistic Insights to Advance HSC-Based Gene and Cell Therapies |
|
| |
Donald B. Kohn, University of California, Los Angeles
HSC Gene Therapy for Immunodeficiencies |
|
| 6:45–7:00 PM |
Meeting Wrap-Up: Outcomes and Future Directions (Joint) (Organizers) |
Sweeney Ballroom A-B |
| 7:00–8:00 PM |
Social Hour with Lite Bites |
Sweeney Ballroom F |
| 8:00–9:00 PM |
Cash Bar |
Sweeney Ballroom F |
